ESR1 and breast cancer: In summary, we demonstrated the repurposing potential of antimalarials and found synergy between DOX/PTX and artesunate, mefloquine, and chloroquine, which makes these combinations a promising approach to treat breast cancer, mainly the non-invasive and estrogen-receptor positive ones.